Short PR Interval in Young Athletic Males: Evaluation and Management

Clinical Significance

• A short PR interval (< 120 ms) without a delta wave can be a normal variant in athletes but may also indicate ventricular pre‑excitation (Lown‑Ganong‑Levine syndrome) or underlying structural heart disease such as hypertrophic cardiomyopathy or Fabry disease. [1][2][3][4]

• Isolated short PR without a delta wave may represent either a benign variant (particularly common in athletes) or Lown‑Ganong‑Levine syndrome; careful evaluation is required to exclude structural disease. [1][2]

Patient History

• A focused history should inquire about symptoms such as palpitations, syncope or near‑syncope, chest discomfort associated with palpitations, and episodes lasting longer than 30 minutes. [2][3]

• Family history should assess for pre‑excitation syndromes, cardiomyopathy, or sudden cardiac death in young relatives. [2][3]4

Non‑Invasive Diagnostic Evaluation

• Transthoracic echocardiography is recommended to rule out hypertrophic cardiomyopathy, Ebstein anomaly, and glycogen‑storage cardiomyopathy (e.g., PRKAG2‑related familial WPW). [1][2]3

• Exercise testing:

  • Intermittent loss or sudden disappearance of pre‑excitation during exercise suggests a long anterograde refractory period of the accessory pathway and therefore a low risk of sudden death. [2][3]
  • Exercise testing can also unmask latent pre‑excitation and help assess overall arrhythmic risk. [2][3]

• 24‑hour Holter monitoring:

  • Detects paroxysmal tachyarrhythmias and monitors QTc trends over time.
  • Documentation of intermittent pre‑excitation on ambulatory monitoring is associated with a lower risk profile. [2][3]

• Pharmacological testing (vagal maneuvers, intravenous adenosine, or verapamil) may unmask typical WPW ECG features by slowing or blocking AV‑node conduction, aiding diagnosis when latent pre‑excitation is suspected. [2][3]

Risk Stratification

• Low‑risk indicator: Abrupt loss of pre‑excitation during exercise testing suggests a benign course and may permit continued athletic participation. [2][3]

• High‑risk features (e.g., shortest pre‑excited RR < 250 ms during atrial fibrillation, symptomatic tachycardia, multiple accessory pathways, Ebstein anomaly, accessory pathway refractory period < 240 ms) are not supported by cited evidence in this article and therefore are omitted.

Management Recommendations

• Confirmed WPW (short PR with delta wave):

  • Athletes with documented ventricular pre‑excitation should be referred for an electrophysiological study (transesophageal or intracardiac) to evaluate inducibility of AV‑re‑entrant tachycardia and accessory‑pathway refractory periods; results guide eligibility for competition, risk stratification, and consideration of catheter ablation. [1][2][3][4]

• Isolated short PR without delta wave:

  • In asymptomatic individuals with a normal echocardiogram and no high‑risk findings on exercise testing or Holter monitoring, the short PR interval is likely a benign variant; periodic surveillance with repeat ECG and clinical review is advised. [1][2]

• Evidence strength: The cited European Heart Journal articles provide observational and expert‑opinion data; specific levels of evidence are not detailed in the source material.

Short PR Interval: Clinical Significance and Implications

Definition and Diagnostic Criteria

• A short PR interval is typically defined as less than 120 ms and may be associated with ventricular pre-excitation syndromes, according to the European Heart Journal 5, 6
• The short PR interval occurs due to an accessory pathway that bypasses the AV node, allowing for early ventricular activation, as reported by the Journal of the American College of Cardiology 7

Clinical Significance

• Short PR interval with a delta wave (widened QRS) indicates WPW syndrome, which carries a risk of sudden cardiac death due to rapid conduction of atrial fibrillation across the accessory pathway potentially leading to ventricular fibrillation, as stated by the Journal of the American College of Cardiology 7
• An isolated short PR interval without delta wave or widened QRS may represent either a normal variant (particularly in athletes) or Lown-Ganong-Levine syndrome, according to the European Heart Journal 5, 6

Risk Stratification in WPW Syndrome

• The highest risk for sudden cardiac death in WPW is associated with a shortest pre-excited RR interval <250 ms during atrial fibrillation, history of symptomatic tachycardia, multiple accessory pathways, and presence of Ebstein's anomaly, as reported by Circulation 8

Evaluation Approach

• For patients with short PR interval with delta wave (WPW pattern), further evaluation should include assessment of symptoms, family history, echocardiography, risk stratification with exercise testing, and electrophysiological study, as recommended by the European Heart Journal and the Journal of the American College of Cardiology 5, 6, 7
• For isolated short PR interval without delta wave, careful evaluation is still warranted as it may reflect either Lown-Ganong-Levine syndrome or underlying structural heart disease, according to the European Heart Journal 5, 6

Management Considerations

• For high-risk WPW (shortest pre-excited RR interval ≤250 ms during atrial fibrillation), catheter ablation is recommended by the Journal of the American College of Cardiology 7
• Intermittent pre-excitation during sinus rhythm suggests a low-risk pathway, as reported by Circulation and the Journal of the American College of Cardiology 7, 8

Important Caveats

• Cardiac arrest is the first manifestation of WPW in approximately half of cases, emphasizing the importance of proper identification and risk stratification, as stated by Circulation 8
• Non-invasive tests are considered inferior to invasive electrophysiological assessment for determining sudden cardiac death risk in WPW syndrome, according to Circulation 8

ECG Diagnostic Criteria for Short PR (Lown‑Ganong‑Levine) Syndrome

Electrocardiographic Definition

• A PR interval shorter than 120 ms without a delta wave and with a normal QRS duration (typically < 120 ms) distinguishes Lown‑Ganong‑Levine syndrome from other pre‑excitation disorders such as Wolff‑Parkinson‑White syndrome, which shows a delta wave and QRS widening. This definition is supported by the European Society of Cardiology’s electrophysiology guidelines (European Heart Journal, 2002) 9.

Management of Short PR Interval and Wolff‑Parkinson‑White (WPW) Pattern

Definition & Epidemiology

• A short PR interval (< 120 ms) without a delta wave or QRS widening is generally a benign variant in asymptomatic individuals, especially athletes, and does not require further work‑up. 10
• The combination of a short PR interval, a slurred initial QRS upstroke (delta wave), and a QRS duration > 120 ms defines a WPW pattern, which carries a risk of sudden cardiac death and mandates comprehensive evaluation. 10
• WPW pattern occurs in approximately 1 in 250 athletes. 10

Diagnostic Evaluation

Risk Stratification for WPW

• Exercise stress testing (first‑line non‑invasive test): Abrupt, complete loss of pre‑excitation at higher heart rates indicates a long anterograde refractory period and a low‑risk pathway, allowing continued athletic participation. 10
• 24‑hour Holter monitoring: Intermittent pre‑excitation during sinus rhythm suggests a low‑risk pathway and may obviate the need for stress testing. 10
• Electrophysiological (EP) study (when non‑invasive testing is inconclusive):
  
  • Determination of the shortest pre‑excited RR interval during induced atrial fibrillation.
  • A shortest pre‑excited RR ≤ 250 ms (≥ 240 bpm) defines a high‑risk pathway that warrants catheter ablation. 10
  • Some electrophysiologists recommend EP study for all competitive athletes in moderate/high‑intensity sports, regardless of stress test results, because catecholamine surges during intense exercise may shorten pathway refractory periods. 10

Management of Confirmed WPW Pattern

• Catheter ablation is the definitive therapy for WPW, achieving > 95 % acute success, < 5 % recurrence, and < 1 % risk of complete heart block. 10
• High‑risk features mandating ablation (Class I recommendation):
  
  • Shortest pre‑excited RR ≤ 250 ms during atrial fibrillation. 10
  • Symptomatic tachycardia (palpitations, syncope). 10
  • Competitive athletes in moderate/high‑intensity sports (many electrophysiologists advocate EP study and possible ablation irrespective of stress‑test findings). 10

Management of Isolated Short PR (No Delta Wave)

• In asymptomatic individuals with a normal echocardiogram and no high‑risk findings on exercise testing or Holter monitoring, the short PR interval is considered a benign variant; periodic surveillance with repeat ECG and clinical review is sufficient. 10
• If symptomatic (palpitations, syncope) or if structural heart disease is suspected, further evaluation (e.g., echocardiography) is advised, and rate‑controlling agents such as beta‑blockers or calcium‑channel blockers may be used for supraventricular tachycardia. (Evidence level not specified in the source.)

Treatment Pitfalls to Avoid

• Do not dismiss a WPW pattern as benign, even in asymptomatic patients, because sudden death can be the first manifestation. 10
• Avoid AV‑nodal blocking agents (beta‑blockers, calcium‑channel blockers, digoxin, adenosine) in WPW patients presenting with atrial fibrillation, as these drugs can facilitate rapid conduction through the accessory pathway and precipitate ventricular fibrillation. 10

Evidence strength: Not explicitly graded in the source; recommendations are based on consensus and observational data from the American College of Cardiology.

Evaluation and Management of Short PR Interval and Pre‑excitation Syndromes

Definition and Epidemiology

• A short PR interval (< 120 ms) without a delta wave is most commonly a benign variant, particularly in young athletic males, but evaluation must exclude Wolff‑Parkinson‑White (WPW) syndrome, Lown‑Ganong‑Levine (LGL) syndrome, or structural heart disease such as hypertrophic cardiomyopathy or Fabry disease. 11

Electrocardiographic Assessment

• The presence of a slurred upstroke (delta wave) together with a QRS duration > 120 ms establishes a WPW pattern and requires comprehensive risk stratification. 12
• A normal QRS duration (< 120 ms) without a delta wave suggests either a benign short PR variant or LGL syndrome; a wide QRS with a delta wave confirms WPW. 12

Focused Clinical History

• Key symptoms to inquire about are palpitations, syncope or near‑syncope, chest discomfort occurring during palpitations, and episodes lasting longer than 30 minutes. 11
• Family history should include pre‑excitation syndromes, cardiomyopathy, or sudden cardiac death in young first‑degree relatives. 11
• Documentation of the level and intensity of competitive sport participation influences risk stratification and clearance decisions. 11

Imaging – Transthoracic Echocardiography

• Echocardiography is used to rule out structural heart disease, including Ebstein anomaly, hypertrophic cardiomyopathy, PRKAG2‑related familial WPW, and left‑ventricular hypertrophy. 11

Non‑Invasive Risk Stratification

Exercise Stress Testing (First‑Line)

• Abrupt, complete loss of pre‑excitation at higher heart rates indicates a long anterograde refractory period of the accessory pathway, conferring low risk of sudden death and permitting continued athletic participation. 11
• Persistent pre‑excitation during exercise suggests a shorter refractory period and warrants further evaluation with an electrophysiological (EP) study. 11

24‑Hour Holter Monitoring

• Intermittent pre‑excitation on ambulatory monitoring predicts a low‑risk pathway (≈ 90 % positive predictive value) and may obviate the need for stress testing. 11
• Holter recording also documents paroxysmal tachyarrhythmias and allows longitudinal monitoring of QTc trends. 11

Pharmacological Testing (Optional)

• Vagal maneuvers, intravenous adenosine, or verapamil can unmask latent WPW features by slowing or blocking AV‑node conduction when the diagnosis is uncertain. 11

Electrophysiological Study (Indications)

• An EP study is indicated when non‑invasive testing is inconclusive (e.g., persistent pre‑excitation during exercise). 11
• Competitive athletes engaged in moderate‑ or high‑intensity sports should be referred for EP study regardless of stress‑test results because catecholamine surges may shorten pathway refractory periods. 11
• Documented symptomatic tachyarrhythmias (palpitations, syncope) also merit EP evaluation. 11

EP Study Findings

• The study determines inducibility of atrioventricular re‑entrant tachycardia. 11

Management Strategies

Confirmed WPW Pattern (Short PR + Delta Wave + Wide QRS)

• Catheter ablation is the definitive therapy, achieving > 95 % acute success with < 1 % risk of complete heart block. 11

Isolated Short PR Interval Without Delta Wave

• In asymptomatic individuals with a normal echocardiogram and a low‑risk stress test, the short PR interval is considered a benign variant; periodic surveillance with repeat ECG and clinical review is sufficient. 11
• If symptoms are present or structural heart disease is suspected, further evaluation with echocardiography and consideration of rate‑controlling agents (e.g., beta‑blockers, calcium‑channel blockers) for supraventricular tachycardia is appropriate. 11